BiotechTube

Gadopentetate dimeglumine (Magnevist, BAY86-6661)

Phase 3Completed
0 watching 0 views this week
0
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Magnetic Resonance Imaging

Conditions

Magnetic Resonance Imaging

Trial Timeline

Jan 1, 2010 → Sep 1, 2010

NCT ID
NCT00937391

About Gadopentetate dimeglumine (Magnevist, BAY86-6661)

Gadopentetate dimeglumine (Magnevist, BAY86-6661) is a phase 3 stage product being developed by Bayer for Magnetic Resonance Imaging. The current trial status is completed. This product is registered under clinical trial identifier NCT00937391. Target conditions include Magnetic Resonance Imaging.

Clinical Trials (1)

NCT IDPhaseStatus
NCT00937391Phase 3Completed

Competing Products

20 competing products in Magnetic Resonance Imaging

See all competitors
ProductCompanyStageHype Score
HRS-9231 + GadobutrolJiangsu Hengrui MedicinePhase 2
52
D1000078 + D1000082 + D1000083 + D1000085AstraZenecaPhase 1
33
Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerPre-clinical
20
Gadobutrol (Gadovist, BAY86-4875) + Gadopentetate Dimeglumine (Magnevist, BAY86-4882)BayerPhase 3
74
Gadoquatrane (BAY1747846)BayerPhase 3
74
Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A) + Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)BayerPhase 2
49
GBCAsBayerPre-clinical
20
Gadobutrol (Gadovist, BAY86-4875)BayerPhase 3
74
BAY1747846BayerPhase 1
30
Gadoterate (Dotarem/Clariscan) + Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerApproved
82
Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + GadoteridolBayerPhase 3
74
Gadobutrol (Gadovist, BAY86-4875)BayerPre-clinical
20
Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + GadoteridolBayerPhase 3
74
Gadobutrol (Gadavist, Gadovist, BAY86-4875)BayerPhase 1
30
Gadobutrol (Gadovist, BAY86-4875)BayerPre-clinical
20
Gadobutrol (Gadavist, BAY86-4875)BayerPhase 1
30
BAY1747846 + Matching placeboBayerPhase 1
30
Gadoquatrane (BAY1747846) 0.03 mmol Gd/kg + Gadoquatrane (BAY1747846) 0.1 mmol Gd/kg + Matching placeboBayerPhase 1
30
Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerPre-clinical
20
Gadoxetate disodium (Eovist/Primovist, BAY86-4873)BayerPhase 3
74

Other Products from Bayer

TelmisartanApproved
82
Clotrimazole vaginal tablet + FluconazoleApproved
82
Levitra (Vardenafil, BAY38-9456)Approved
82
Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved
82
Rivaroxaban 20 MG + WarfarinApproved
82